Market Cap (In KRW)
106.01 Billion
Revenue (In KRW)
5.19 Billion
Net Income (In KRW)
-13.41 Billion
Avg. Volume
35.36 Thousand
- Currency
- KRW
- Country
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 4650.0-11100.0
- PE
- -
- EPS
- -
- Beta Value
- 0.739
- ISIN
- KR7246710008
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Industry
- CEO
- Wonsoo Yun
- Employee Count
- -
- Website
- https://www.tnrbiofab.com
- Ipo Date
- 2018-11-28
- Details
- T&R Biofab Co., Ltd. engages in the research and development of medical devices for transplantation and tissue regeneration in the areas of orthopedics, plastic surgery, and dentistry. It offers craniomaxillofacial meshes, dental meshes, and patient specific implants; and bioinks for 3D bioprinting and cell culture, stem cell research and delivery, and coating of scaffold and cultural dishes. The company was founded in 2013 and is based in Siheung-si, South Korea.
More Stocks
-
BC-PA
-
GFPT
-
NEM
-
002116
-
STLXFStellar AfricaGold Inc.
STLXF
-
2086
-
6682
-
TESTesmec S.p.A.
TES